Nickl, V.; Schulz, E.; Salvador, E.; Trautmann, L.; Diener, L.; Kessler, A.F.; Monoranu, C.M.; Dehghani, F.; Ernestus, R.-I.; Löhr, M.;
et al. Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields). Cancers 2022, 14, 5177.
https://doi.org/10.3390/cancers14215177
AMA Style
Nickl V, Schulz E, Salvador E, Trautmann L, Diener L, Kessler AF, Monoranu CM, Dehghani F, Ernestus R-I, Löhr M,
et al. Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields). Cancers. 2022; 14(21):5177.
https://doi.org/10.3390/cancers14215177
Chicago/Turabian Style
Nickl, Vera, Ellina Schulz, Ellaine Salvador, Laureen Trautmann, Leopold Diener, Almuth F. Kessler, Camelia M. Monoranu, Faramarz Dehghani, Ralf-Ingo Ernestus, Mario Löhr,
and et al. 2022. "Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)" Cancers 14, no. 21: 5177.
https://doi.org/10.3390/cancers14215177
APA Style
Nickl, V., Schulz, E., Salvador, E., Trautmann, L., Diener, L., Kessler, A. F., Monoranu, C. M., Dehghani, F., Ernestus, R.-I., Löhr, M., & Hagemann, C.
(2022). Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields). Cancers, 14(21), 5177.
https://doi.org/10.3390/cancers14215177
